In conclusion, unlike other S100 proteins, S100A11 appears to have weaker cytokine action in RA than other participating proteins, and the systemic level of S100A11 cannot be considered as a biomarker of disease activity. The gene discussed is S100A11; the disease is rheumatoid arthritis.